| Application no. and date | 20715421.2 (espacenet) (Federated) (European Patent Register), 20200407 | | Patent/reg. no. and date | DK/EP 3952868, 20250813 | | Publication date | 20220216 | | Priority no. and date | EP 19305463, 20190409 | | EP pub. no. and date |
EP 3952868 20220216 | | Effective date | | | Applicant/owner | Genfit, 885 avenue Eugène Avinée
59120 Loos, FR | | Applicant ref. no. | | | Inventor | WALCZAK, Robert, Résidence Parc d'Isly
13B rue Delezenne
59000 Lille, FR,
PARROCHE, Peggy, 16 bis rue Charles Gilquin
59120 Loos, FR | | Representative | | | Opponent | | | IPC Class | A61K 31/192 (2006.01) , A61K 31/426 (2006.01) , A61K 45/06 (2006.01) , A61K 9/00 (2006.01) , A61P 1/16 (2006.01) , A61P 29/00 (2006.01) , A61P 37/00 (2006.01) , A61P 43/00 (2006.01) | | Title | COMBINATION OF NITAZOXANIDE AND ELAFIBRANOR FOR THE TREATMENT OF IMMUNE DISEASES OR INFLAMMATION | | Int. application no. | EP2020059941 | | Int. publication no. | WO2020208044 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
